Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis

Albani Clara, 2014, Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes, Acta Trop., 140, 61, 10.1016/j.actatropica.2014.08.007 Albani, 2015, In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis, Vet. Parasitol., 212, 193, 10.1016/j.vetpar.2015.06.030 Aulner, 2019, Next-generation phenotypic screening in early drug discovery for infectious diseases, Trends Parasitol., 35, 559, 10.1016/j.pt.2019.05.004 Bakhtiar, 2019, Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects, Parasitol. Res., 10.1007/s00436-019-06416-5 Basra, 2013, Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., 56, e68, 10.1093/cid/cis976 Baumann, 2019, Worldwide literature on epidemiology of human alveolar echinococcosis: a systematic review of research published in the twenty-first century, Infection, 47, 703, 10.1007/s15010-019-01325-2 Bebezov, 2018, Intense focus of alveolar echinococcosis, south Kyrgyzstan, Emerg. Infect. Dis., 24, 1119, 10.3201/eid2406.161641 Boubaker, 2015, Prevention and immunotherapy of secondary murine alveolar echinococcosis employing recombinant EmP29 antigen, PLoS Neglected Trop. Dis., 9, 10.1371/journal.pntd.0003795 Bouwknegt, 2018, Prioritisation of food-borne parasites in Europe, 2016, Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull., 23 Brehm, 2014, On the importance of targeting parasite stem cells in anti-echinococcosis drug development, Parasite Paris France, 21, 72, 10.1051/parasite/2014070 Brunetti, 2010, Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans, Acta Trop., 114, 1, 10.1016/j.actatropica.2009.11.001 Bryant, 1970, Electron transport in parasitic helminths and protozoa, Adv. Parasitol., 8, 139, 10.1016/S0065-308X(08)60253-5 Chauchet, 2014, Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., 59, 1095, 10.1093/cid/ciu520 Cirilli, 2017, The sodium salt of the enantiomers of ricobendazole: preparation, solubility and chiroptical properties, J. Pharmaceut. Biomed. Anal., 139, 1, 10.1016/j.jpba.2017.01.057 Corrêa Soares, 2009, Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols, PLoS Neglected Trop. Dis., 3, e477, 10.1371/journal.pntd.0000477 Cruikshank, 2004, Potent block of Cx36 and Cx50 gap junction channels by mefloquine, Proc. Natl. Acad. Sci. U. S. A, 101, 12364, 10.1073/pnas.0402044101 Edgar, 2002, The human L-threonine 3-dehydrogenase gene is an expressed pseudogene, BMC Genet., 3, 18, 10.1186/1471-2156-3-18 Egan, 1994, Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment), FEBS Lett., 352, 54, 10.1016/0014-5793(94)00921-X Emery, 1998, In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis, Parasite Immunol., 20, 81, 10.1046/j.1365-3024.1998.00131.x Enkai, 2020, Mitochondrial complex III in larval stage of Echinococcus multilocularis as a potential chemotherapeutic target and in vivo efficacy of atovaquone against primary hydatid cysts, Parasitol. Int., 75, 10.1016/j.parint.2019.102004 Förster, 2019, The role of fibroblast growth factor signalling in Echinococcus multilocularis development and host-parasite interaction, PLoS Neglected Trop. Dis., 13, 10.1371/journal.pntd.0006959 Geary, 2015, Anthelmintic drug discovery: into the future, J. Parasitol., 101, 125, 10.1645/14-703.1 Gelmedin, 2008, Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors, Biochem. Pharmacol., 76, 1068, 10.1016/j.bcp.2008.08.020 Gelmedin, 2010, Molecular characterisation of MEK1/2- and MKK3/6-like mitogen-activated protein kinase kinases (MAPKK) from the fox tapeworm Echinococcus multilocularis, Int. J. Parasitol., 40, 555, 10.1016/j.ijpara.2009.10.009 Godot, 2003, IFN alpha-2a protects mice against a helminth infection of the liver and modulates immune responses, Gastroenterology, 124, 1441, 10.1016/S0016-5085(03)00273-7 Gorgas, 2017, To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis, Parasitology, 144, 937, 10.1017/S0031182017000051 Gottstein, 2015, Threat of alveolar echinococcosis to public health - a challenge for Europe, Trends Parasitol., 10.1016/j.pt.2015.06.001 Gottstein, 2015, Susceptibility versus resistance in alveolar echinococcosis (larval infection with Echinococcus multilocularis), 213, 103 Grüner, 2017, Comprehensive diagnosis and treatment of alveolar echinococcosis: a single-center, long-term observational study of 312 patients in Germany, GMS Infect. Dis., 1–12 Haby, 2020, Systematic review of the effectiveness of selected drugs for preventive chemotherapy for Taenia solium taeniasis, PLoS Neglected Trop. Dis., 14, 10.1371/journal.pntd.0007873 Hemer, 2012, In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae, Int. J. Antimicrob. Agents, 40, 458, 10.1016/j.ijantimicag.2012.07.007 Hizem, 2019, Activity of Thymus capitatus essential oil components against in vitro cultured Echinococcus multilocularis metacestodes and germinal layer cells, Parasitology, 1 Huang, 2018, The effects of taxanes, vorinostat and doxorubicin on growth and proliferation of Echinococcus multilocularis metacestodes assessed with magnetic resonance imaging and simultaneous positron emission tomography, Oncotarget, 9, 9073, 10.18632/oncotarget.24142 Hübner, 2010, Effects of in vitro exposure of Echinococcus multilocularis metacestodes to cytostatic drugs on in vivo growth and proliferation of the parasite, Parasitol. Res., 107, 459, 10.1007/s00436-010-1892-0 Jebbawi, F., Bellanger, A.-P., Lundström-Stadelmann, B., Rufener, R., Dosch, M., Beldi, G., Millon, L., Gottstein, Bruno, B., Wang, J., Submitted for publication. Innate and Adaptive Immunity Interactions via PD-1/PDL-1 Immune Checkpoint Blockade in Murine Alveolar Echinococcosis. Joekel, 2018, Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model, Exp. Parasitol., 188, 65, 10.1016/j.exppara.2018.04.002 Kadri, 2018, Niclosamide, a drug with many (Re)purposes, ChemMedChem, 13, 1088, 10.1002/cmdc.201800100 Keiser, 2009, Mefloquine--an aminoalcohol with promising antischistosomal properties in mice, PLoS Neglected Trop. Dis., 3, 10.1371/journal.pntd.0000350 Keiser, 2010, Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., 50, 1205, 10.1086/651682 Keiser, 2009, Dose-response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro, Parasitol. Res., 105, 261, 10.1007/s00436-009-1395-z Keiser, 2014, Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial, PLoS Neglected Trop. Dis., 8, 10.1371/journal.pntd.0002975 Kern, 2017, The echinococcoses: diagnosis, clinical management and burden of disease, Adv. Parasitol., 96, 259, 10.1016/bs.apar.2016.09.006 Kern, 2008, Critical appraisal of nitazoxanide for the treatment of alveolar echinococcosis, Am. J. Trop. Med. Hyg., 79, 119 Kita, 2003, Parasite mitochondria as drug target: diversity and dynamic changes during the life cycle, Curr. Med. Chem., 10, 2535, 10.2174/0929867033456549 Komuniecki, 1995, Carbohydrate and energy metabolism in helminths, 10.1016/B978-012473345-9/50005-2 Koziol, 2014, The unique stem cell system of the immortal larva of the human parasite Echinococcus multilocularis, EvoDevo, 5, 10, 10.1186/2041-9139-5-10 Küster, 2014, Amino ozonides exhibit in vitro activity against Echinococcus multilocularis metacestodes, Int. J. Antimicrob. Agents, 43, 40, 10.1016/j.ijantimicag.2013.09.012 Küster, 2014, Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model, Int. J. Antimicrob. Agents, 43, 335, 10.1016/j.ijantimicag.2014.01.013 Küster, 2011, In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis, Antimicrob. Agents Chemother., 55, 713, 10.1128/AAC.01392-10 Küster, 2015, Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin, Int. J. Antimicrob. Agents, 46, 546, 10.1016/j.ijantimicag.2015.07.016 Lachenmayer, 2019, Elevated incidence of alveolar echinococcosis in immunocompromised patients, Food Waterborne Parasitol., 10.1016/j.fawpar.2019.e00060 Li, 2017, Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway, Can. J. Physiol. Pharmacol., 95, 43, 10.1139/cjpp-2016-0124 Lim, 1985, The anticholinesterase activity of mefloquine, Clin. Exp. Pharmacol. Physiol., 12, 527, 10.1111/j.1440-1681.1985.tb00904.x Liu, 2016, Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling pathway, Biochem. Biophys. Res. Commun., 470, 350, 10.1016/j.bbrc.2016.01.046 Lundström-Stadelmann, 2019, The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis, Food Waterborne Parasitol., 15, 10.1016/j.fawpar.2019.e00040 Manneck, 2010, Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni, Parasitology, 137, 85, 10.1017/S0031182009990965 Matsumoto, 2008, Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis, Antimicrob. Agents Chemother., 52, 164, 10.1128/AAC.00378-07 McArdle, 2005, Mefloquine inhibits cholinesterases at the mouse neuromuscular junction, Neuropharmacology, 49, 1132, 10.1016/j.neuropharm.2005.06.011 McManus, 1978, Differences in the chemical composition and carbohydrate metabolism of Echinococcus granulosus (horse and sheep strains) and E. multilocularis, Parasitology, 77, 103, 10.1017/S0031182000048769 Milatovic, 2011, Mefloquine neurotoxicity is mediated by non-receptor tyrosine kinase, Neurotoxicology, 32, 578, 10.1016/j.neuro.2011.01.001 Millerioux, 2013, The threonine degradation pathway of the Trypanosoma brucei procyclic form: the main carbon source for lipid biosynthesis is under metabolic control, Mol. Microbiol., 90, 114, 10.1111/mmi.12351 Müller, 2016, Drug target identification in protozoan parasites, Expet Opin. Drug Discov., 11, 815, 10.1080/17460441.2016.1195945 Naguleswaran, 2006, In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus, Antimicrob. Agents Chemother., 50, 3770, 10.1128/AAC.00578-06 Nikendei, 2019, Psychological burden and resilience factors in patients with Alveolar Echinococcosis - a cross-sectional study, PLoS Neglected Trop. Dis., 13, 10.1371/journal.pntd.0007082 Njouendou, 2018, Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections, Parasites Vectors, 11, 223, 10.1186/s13071-018-2799-3 Njouendou, 2019, In vitro maintenance of Mansonella perstans microfilariae and its relevance for drug screening, Exp. Parasitol., 206, 10.1016/j.exppara.2019.107769 Panic, 2014, Repurposing drugs for the treatment and control of helminth infections, Int. J. Parasitol. Drugs Drug Resist., 4, 185, 10.1016/j.ijpddr.2014.07.002 Panic, 2017, Immunohistochemical investigations of treatment with Ro 13-3978, praziquantel, oxamniquine, and mefloquine in schistosoma mansoni-infected mice, Antimicrob. Agents Chemother., 61, 10.1128/AAC.01142-17 Pensel, 2018, Albendazole nanocrystals in experimental alveolar echinococcosis: enhanced chemoprophylactic and clinical efficacy in infected mice, Vet. Parasitol., 251, 78, 10.1016/j.vetpar.2017.12.022 Pfister, 1989, Interferon gamma in experimental echinococcosis, J. Interferon Res., 9, S136 Polish, 2020, Echinococcus multilocularis: first European haplotype identified in the United States: an emerging disease?, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., 10.1093/cid/ciaa245 Reuter, 2006, In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae, Antimicrob. Agents Chemother., 50, 2966, 10.1128/AAC.00476-06 Reuter, 2003, Effect of amphotericin B on larval growth of Echinococcus multilocularis, Antimicrob. Agents Chemother., 47, 620, 10.1128/AAC.47.2.620-625.2003 Ritler, 2019, In vitro metabolomic footprint of the Echinococcus multilocularis metacestode, Sci. Rep., 9, 10.1038/s41598-019-56073-y Robertson, 2018, Parasites in food: from a neglected position to an emerging issue, Adv. Food Nutr. Res., 86, 71, 10.1016/bs.afnr.2018.04.003 Romig, 2017, Ecology and life cycle patterns of echinococcus species, Adv. Parasitol., 95, 213, 10.1016/bs.apar.2016.11.002 Rufener, 2018, Repurposing of an old drug: in vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis, Int. J. Parasitol. Drugs Drug Resist., 8, 440, 10.1016/j.ijpddr.2018.10.011 Rufener, 2018, Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis, Int. J. Parasitol. Drugs Drug Resist., 8, 331, 10.1016/j.ijpddr.2018.06.004 Sailer, 1997, Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome, J. Pediatr., 130, 320, 10.1016/S0022-3476(97)70364-0 Salm, 2019, Surgical treatment strategies for hepatic alveolar echinococcosis, Food Waterborne Parasitol., 15, 10.1016/j.fawpar.2019.e00050 Schmidberger, 2018, Health-related quality of life in patients with alveolar echinococcosis: a cross-sectional study, Infection Schubert, 2014, Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1, PLoS Neglected Trop. Dis., 8, 10.1371/journal.pntd.0002870 Sharma, 2012, Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent, Canc. Lett., 326, 143, 10.1016/j.canlet.2012.07.029 Siles-Lucas, 2018, Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets, PLoS Neglected Trop. Dis., 12, 10.1371/journal.pntd.0006422 Soukhathammavong, 2011, Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial, Lancet Infect. Dis., 11, 110, 10.1016/S1473-3099(10)70250-4 Spicher, 2008, In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes, Exp. Parasitol., 119, 475, 10.1016/j.exppara.2008.02.012 Spicher, 2008, In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives, Antimicrob. Agents Chemother., 52, 3447, 10.1128/AAC.00553-08 Spiliotis, 2008, Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles, Int. J. Parasitol., 38, 1025, 10.1016/j.ijpara.2007.11.002 Spiliotis, 2004, Long-term in vitro cultivation of Echinococcus multilocularis metacestodes under axenic conditions, Parasitol. Res., 92, 430, 10.1007/s00436-003-1046-8 Stadelmann, 2011, In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes, Antimicrob. Agents Chemother., 55, 4866, 10.1128/AAC.00478-11 Stadelmann, 2016, Screening of the open source malaria box reveals an early lead compound for the treatment of alveolar echinococcosis, PLoS Neglected Trop. Dis., 10, 10.1371/journal.pntd.0004535 Stadelmann, 2010, Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes, J. Antimicrob. Chemother., 65, 512, 10.1093/jac/dkp490 Stettler, 2003, In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes, Antimicrob. Agents Chemother., 47, 467, 10.1128/AAC.47.2.467-474.2003 Tappe, 2009, Limitations of amphotericin B and nitazoxanide in the treatment of alveolar echinococcosis, Ann. Trop. Med. Parasitol., 103, 177, 10.1179/136485909X385036 Thompson, 2017, Biology and systematics of echinococcus, Adv. Parasitol., 95, 65, 10.1016/bs.apar.2016.07.001 Tickell-Painter, 2017, Mefloquine for preventing malaria during travel to endemic areas, Cochrane Database Syst. Rev., 10 Tielens, 1994, Energy generation in parasitic helminths, Parasitol. Today Pers. Ed, 10, 346, 10.1016/0169-4758(94)90245-3 Torgerson, 2015, World health organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: a data synthesis, PLoS Med., 12, 10.1371/journal.pmed.1001920 Townson, 1990, The effects of ivermectin used in combination with other known antiparasitic drugs on adult Onchocerca gutturosa and O. volvulus in vitro, Trans. R. Soc. Trop. Med. Hyg., 84, 411, 10.1016/0035-9203(90)90340-K Trotz-Williams, 2017, Public health follow-up of suspected exposure to echinococcus multilocularis in southwestern ontario, Zoonoses Public Health, 64, 460, 10.1111/zph.12326 Ullio Gamboa, 2019, Albendazole-lipid nanocapsules: optimization, characterization and chemoprophylactic efficacy in mice infected with Echinococcus granulosus, Exp. Parasitol., 198, 79, 10.1016/j.exppara.2019.02.002 Walter, 1987, Filaricidal effect of mefloquine on adults and microfilariae of Brugia patei and Brugia malayi, Trop. Med. Parasitol. Off. Organ Dtsch. Tropenmedizinische Ges. Dtsch. Ges. Tech. Zusammenarbeit GTZ, 38, 55 Wang, 2009, Dependence of mouse embryonic stem cells on threonine catabolism, Science, 325, 435, 10.1126/science.1173288 Wang, 2018, Immunotherapy of alveolar echinococcosis via PD-1/PD-L1 immune checkpoint blockade in mice, Parasite Immunol., 40, 10.1111/pim.12596 Wong, 2017, Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis, Nat. Microbiol., 2, 10.1038/nmicrobiol.2017.31 Xu, 2018, Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells, Canc. Sci., 109, 1220, 10.1111/cas.13540 Yuan, 2016, Efficacy of osthole for Echinococcus granulosus in vitro and Echinococcus multilocularis in vivo, Vet. Parasitol., 226, 38, 10.1016/j.vetpar.2016.05.016 Zhou, 2006, Mefloquine enhances nigral gamma-aminobutyric acid release via inhibition of cholinesterase, J. Pharmacol. Exp. Therapeut., 317, 1155, 10.1124/jpet.106.101923 Zingg, 2004, Alveolar echinococcosis of the liver in an adult with human immunodeficiency virus type-1 infection, Infection, 32, 299, 10.1007/s15010-004-3134-9